Clinical Trials Search

Titlesort ascending Intervention NCT ID Sponsor Status
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage... Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration, Radiation Therapy NCT03414970 Alliance for Clinical Trials in Oncology Recruiting
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer Comprehensive Geriatric Assessment, Quality-of-Life Assessment, Survey Administration NCT02054741 Supriya Mohile Active, not recruiting
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment Quality-of-Life Assessment, Questionnaire Administration NCT03516942 ECOG-ACRIN Cancer Research Group Active, not recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Active, not recruiting
Evaluation of Mammographic Breast Density in Participants With Hormone Receptor-Negative Breast... Biospecimen Collection, Screening Mammography NCT03609021 Alliance for Clinical Trials in Oncology Recruiting
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous... Erlotinib Hydrochloride, Erlotinib NCT02961374 National Cancer Institute (NCI) Active, not recruiting
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver Erlotinib Hydrochloride, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Erlotinib NCT02273362 National Cancer Institute (NCI) Active, not recruiting
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure... Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration NCT01790152 Children's Oncology Group Recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Interview, Questionnaire Administration NCT03963739 Wake Forest University Health Sciences Recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III... Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT04137107 Alliance for Clinical Trials in Oncology Recruiting

Pages